Harmony Biosciences Holdings, INC. (HRMY) — 10-Q Filings

All 10-Q filings from Harmony Biosciences Holdings, INC.. Browse 6 Quarterly Report reports with AI-powered summaries and risk analysis.

10-Q Filings (6)

Harmony Biosciences Soars on Strong WAKIX Sales, Strategic Acquisitions — Nov 4, 2025 Risk: medium
Harmony Biosciences Holdings, Inc. (HRMY) reported robust financial performance for the nine months ended September 30, 2025, with net product revenue increasin
Harmony Biosciences' WAKIX Sales Drive Strong Q2 Growth — Aug 5, 2025 Risk: medium
Harmony Biosciences Holdings, Inc. reported strong financial performance for the quarter ended June 30, 2025, driven primarily by increased WAKIX sales. Revenue
Harmony Biosciences Files Q1 2025 10-Q — May 6, 2025 Risk: medium
Harmony Biosciences Holdings, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results and provided updates on its busin
Harmony Biosciences Q3 2024 10-Q Filing — Oct 29, 2024 Risk: medium
Harmony Biosciences Holdings, Inc. filed its 10-Q for the period ending September 30, 2024. The company reported its financial results and provided updates on i
Harmony Biosciences Files Q2 2024 10-Q — Aug 6, 2024 Risk: medium
Harmony Biosciences Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The company reported its financial performance and business operations. K
Harmony Biosciences Holdings, Inc. Files 10-Q for Period Ending March 31, 2024 — Apr 30, 2024 Risk: low
Harmony Biosciences Holdings, Inc. (HRMY) filed a Quarterly Report (10-Q) with the SEC on April 30, 2024. Harmony Biosciences Holdings, Inc. filed a 10-Q for th

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX